Logo do repositório
 
Miniatura indisponível
Publicação

Diabetes risk assessment: clinical screening tools

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
COM_Rúben Fernandes 3.pdf212.74 KBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

The epidemic of type 2 diabetes (T2D) continues to soar worldwide. Driven by changes in human habits, from availability of energy dense processed foods to the decrease of physical activity, T2D constitutes already a heavy burden of disease and a worrisome barrier for the sustainability of National Health Systems. Indeed, it affects 415 million people (8.8% prevalence), was responsible for 5.0 million deaths in 2015, and is estimated to cost 1/9 of all Health expenses. Within Europe, Portugal is reported as having the highest prevalence of diabetes: an estimated 9.6% by World Standard Population. But if we take into consideration the age distribution of the Portuguese population, then estimates increase to 12.9%. This means that 1 million Portuguese have diabetes, with almost half of these still undiagnosed. Additionally, 2 million (a third of the adult population) are estimated to have intermediate hyperglycemia (or prediabetes), being largely unaware of this condition.

Descrição

Palavras-chave

Type 2 diabetes mellitus Prediabetes Diabetes risk assessment Diabetes risk score

Contexto Educativo

Citação

Macedo, J. M., Baylina, P., & Fernandes, R. (2019). Diabetes risk assessment: Clinical screening tools. Workshop on R&D Projects: Proceedings, 24–26.

Projetos de investigação

Unidades organizacionais

Fascículo